Featured Article

FDA Offers Further RBM Guidance Stressing Data Quality Oversight

Since finalizing its risk-based monitoring guidance in 2013, the FDA is providing additional information in a new Q&A that reinforces the importance of performing risk assessments for all studies.

Meet SPOT: Transforming Site Monitoring Practices with Adaptive Intelligence
A New Era of Automation: Improving Efficiency & Outcomes with Intelligent Medical Coding
Press Release
CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations